ADC Therapeutics
ADCT
$4.34
Share price
-2.25%
Change (1 day)
123.71%
Change (1 year)
Categories
ADC Therapeutics (ADCT) - Cash on Hand
Cash on Hand as of December 2023 : $0.27 B
According to ADC Therapeutics's latest financial reports the company has $0.27 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
ADC Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | -14.66% |
| 2022-12-31 | $0.32 B | -30.03% |
| 2021-12-31 | $0.46 B | 6.23% |
| 2020-12-31 | $0.43 B | 280.09% |
| 2019-12-31 | $0.11 B | -16.75% |
| 2018-12-31 | $0.13 B | -47.17% |
| 2017-12-31 | $0.26 B | 82.89% |
| 2016-12-31 | $0.14 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -25.27% | 🇺🇸 USA |